New Use of Opioids Increases Risk of Death in Dementia
New Research presented at the AAIC shows new opioid use in older adults with dementia is associated with a significantly increased risk of death.
All posts by Alzheimer's Association
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.
Positive Results on Donanemab Phase 3 Trial Reported
New data reported by Eli Lilly from the TRAILBLAZER-ALZ 2 trial of donanemab at the AAIC, shows that the drug is effective in delaying Alzheimer’s progression.
First-Ever US County-Level Alzheimer’s Prevalence Estimates
The first-ever county-level estimates of the prevalence of people with Alzheimer’s dementia, in all 3,142 United States counties. Released at AAIC
CRISPR / Gene Editing Creates New Treatment Possibilities
New Research presented at the AAIC shows provide details on two new CRISPR-based strategies which offer hope for next-generation Alzheimer’s treatments.
Catch-up: Risk Reduction Summit
Day One from the Alzheimer’s Association & Public Health Center of Excellent, Dementia Risk Reduction Summit. covering Changing Organisational Practices
ISTAART Is 10,000 Members Strong
ISTAART has achieved the amazing milestone of welcoming the 10,000th member to its amazing community of scientists, clinicians and dementia professionals
The New ISTAART Web Experience
The Alzheimer’s Association has enhanced the way ISTAART members connect online with a new main dashboard, updated PIA pages and more.
ISTAART “Basics of…” Webinar Series
Special series of ISTAART webinars throughout April providing educational content from experts in the field of Alzheimer’s and dementia research.
ISTAART Blog – Fostering inclusivity in dementia research and teams
ISTAART Partnering with Research Participants PIA Blog. Dr Diana Karamacoska shares tips on making research accessible, inclusive & equitable (also in Spanish)
Experiences of Racism Associated with Poor Memory, Increased Cognitive Decline
Experiences of racism are associated with lower memory scores & worse cognition in midlife, in old age, and especially among Black people
Persistent Loss of Smell Due to COVID-19 Closely Connected to Long-Lasting Cognitive Problems
Persistent loss of smell may be a better predictor of long-term cognitive and functional impairment than severity of the initial COVID-19 infection
ALZ-NET: A Long-Term Data Collection and Sharing Network for New Treatments
ALZ-NET — a new platform that will collect long-term clinical and safety data from patients treated with Alzheimer’s disease therapies